BIOGEN INC. Prepaid Taxes
BIOGEN INC. (BIIB) had Prepaid Taxes of $661.60 million as of 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidTaxes · last filed 2026-04-29
- 2015-12-31: Prepaid Taxes 550.60M EUR.
EUR
| Period end | Prepaid Taxes |
|---|---|
| 2015-12-31 | 550.60M EUR 10-Q · filed 2016-04-21 |
USD
| Period end | Prepaid Taxes |
|---|---|
| 2026-03-31 | $661.60M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $693.60M 10-Q · filed 2026-04-29 |
| 2024-12-31 | $307.20M 10-K · filed 2026-02-06 |
| 2018-12-31 | $271.20M 10-K · filed 2019-02-06 |
| 2018-09-30 | $431.80M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $508.30M 10-Q · filed 2018-07-24 |
| 2018-03-31 | $587.50M 10-Q · filed 2018-04-24 |
| 2017-12-31 | $657.60M 10-K · filed 2019-02-06 |
| 2017-09-30 | $714.40M 10-Q · filed 2017-10-24 |
| 2017-06-30 | $881.40M 10-Q · filed 2017-07-25 |
| 2017-03-31 | $935.60M 10-Q · filed 2017-04-25 |
| 2016-12-31 | $817.00M 10-K · filed 2018-02-01 |
| 2016-09-30 | $725.30M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $704.10M 10-Q · filed 2016-07-21 |
| 2016-03-31 | $613.20M 10-Q · filed 2016-04-21 |
| 2015-12-31 | $550.60M 10-K · filed 2017-02-02 |
| 2015-06-30 | $280.50M 10-Q · filed 2015-07-24 |
| 2014-12-31 | $57.60M 10-K · filed 2016-02-03 |
| 2011-12-31 | $15.20M 10-K · filed 2012-02-03 |
| 2011-09-30 | $29.40M 10-Q · filed 2011-10-28 |
| 2011-06-30 | $33.10M 10-Q · filed 2011-07-26 |
| 2011-03-31 | $22.90M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $31.40M 10-K · filed 2012-02-03 |
| 2009-12-31 | $11.00M 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |